Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion description "[Inhibiting antiapoptotic BCL-2 and its relatives is an attractive strategy for sensitizing lymphoid malignancies to drugs but it has been largely unsuccessful for melanoma and other solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion evidence source_evidence_literature NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion SIO_000772 22173547 NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion wasDerivedFrom befree-20150227 NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion wasGeneratedBy ECO_0000203 NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.